These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25695958)

  • 41. Sex differences in behavioral and neurochemical effects of gonadectomy and aromatase inhibition in rats.
    Kokras N; Pastromas N; Papasava D; de Bournonville C; Cornil CA; Dalla C
    Psychoneuroendocrinology; 2018 Jan; 87():93-107. PubMed ID: 29054014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.
    Swami S; Krishnan AV; Wang JY; Jensen K; Peng L; Albertelli MA; Feldman D
    Horm Cancer; 2011 Jun; 2(3):190-202. PubMed ID: 21686077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Xenograft models for aromatase inhibitor studies.
    Brodie A; Sabnis G; Macedo L
    J Steroid Biochem Mol Biol; 2007; 106(1-5):119-24. PubMed ID: 17611101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
    Tivnan A; Heilinger T; Ramsey JM; O'Connor G; Pokorny JL; Sarkaria JN; Stringer BW; Day BW; Boyd AW; Kim EL; Lode HN; Cryan SA; Prehn JH
    Oncotarget; 2017 Mar; 8(10):16605-16620. PubMed ID: 28178667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle.
    Yapura MJ; Mapletoft RJ; Singh J; Pierson R; Naile J; Giesy JP; Chang H; Higley E; Hecker M; Adams GP
    Reprod Fertil Dev; 2012; 24(4):631-40. PubMed ID: 22541551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells.
    De Santi M; Carloni E; Galluzzi L; Diotallevi A; Lucarini S; Magnani M; Brandi G
    Anticancer Agents Med Chem; 2015; 15(7):896-904. PubMed ID: 25612679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts.
    Chottanapund S; Van Duursen MB; Navasumrit P; Hunsonti P; Timtavorn S; Ruchirawat M; Van den Berg M
    Toxicol In Vitro; 2014 Oct; 28(7):1215-21. PubMed ID: 24929094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
    Kumru S; Yildiz AA; Yilmaz B; Sandal S; Gurates B
    Gynecol Endocrinol; 2007 Oct; 23(10):556-61. PubMed ID: 17952760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aromatase inhibitor regulates let-7 expression and let-7f-induced cell migration in endometrial cells from women with endometriosis.
    Cho S; Mutlu L; Zhou Y; Taylor HS
    Fertil Steril; 2016 Sep; 106(3):673-80. PubMed ID: 27320036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letrozole Decreased Testosterone-Induced Cell Proliferation and Prolactin Secretion also Increased Apoptosis in MMQ and GH3 Rat Prolactinoma Cell Lines.
    Selek A; Halbutoğulları ZSU; Aydemir Çİ; Cetinarslan B; Canturk Z; Tarkun I; Erman G; Subaşı C; Erdal K
    Mol Neurobiol; 2023 May; 60(5):2442-2454. PubMed ID: 36662360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
    Tekmal RR; Kirma N; Gill K; Fowler K
    Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenges in the endocrine management of breast cancer.
    Mouridsen HT; Rose C; Brodie AH; Smith IE
    Breast; 2003 Aug; 12 Suppl 2():S2-19. PubMed ID: 14659138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C; Keam SJ
    Pharmacoeconomics; 2006; 24(5):495-517. PubMed ID: 16706574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aromatase inhibitor letrozole downregulates steroid receptor coactivator-1 in specific brain regions that primarily related to memory, neuroendocrine and integration.
    Bian C; Zhao Y; Guo Q; Xiong Y; Cai W; Zhang J
    J Steroid Biochem Mol Biol; 2014 May; 141():37-43. PubMed ID: 24434281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat.
    Sinha S; Kaseta J; Santner SJ; Demers LM; Bremmer WJ; Santen RJ
    Breast Cancer Res Treat; 1998 Mar; 48(1):45-51. PubMed ID: 9541188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
    Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
    Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypogonadism Associated with Cyp19a1 (Aromatase) Posttranscriptional Upregulation in Celf1 Knockout Mice.
    Boulanger G; Cibois M; Viet J; Fostier A; Deschamps S; Pastezeur S; Massart C; Gschloessl B; Gautier-Courteille C; Paillard L
    Mol Cell Biol; 2015 Sep; 35(18):3244-53. PubMed ID: 26169831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
    Wang XQ; Aka JA; Li T; Xu D; Doillon CJ; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():188-197. PubMed ID: 28645527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding resistance to endocrine agents: molecular mechanisms and potential for intervention.
    Sabnis G; Brodie A
    Clin Breast Cancer; 2010 Feb; 10(1):E6-E15. PubMed ID: 20133251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.